ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,133Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 944

$1.94M Total Retail Price of All Prescriptions

Rank: 2 out of 944

543 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 543 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 10,410 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$120 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
HYDROCHLOROTHIAZIDE 659 549 1 9
SIMVASTATIN 477 365 2 1
AMLODIPINE BESYLATE 448 357 3 5
LEVOTHYROXINE SODIUM 380 296 4 2
OMEPRAZOLE 342 260 5 4
LISINOPRIL 338 272 6 3
HYDROCODONE-ACETAMINOPHEN 315 127 S3 7 10
METOPROLOL TARTRATE 314 236 8 8
METFORMIN HCL 301 254 9 12
PRAVASTATIN SODIUM 296 213 10 17
MELOXICAM 290 210 11 68
WARFARIN SODIUM 277 193 12 7
FUROSEMIDE 272 192 13 6
ALLOPURINOL 213 145 14 22
TAMSULOSIN HCL 208 174 15 27
ATORVASTATIN CALCIUM 207 185 16 13
METOPROLOL SUCCINATE 203 166 17 14
GLYBURIDE 193 162 R 18 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 187 162 19 29
GABAPENTIN 183 85 20 18
PAROXETINE HCL 176 107 21 64
ATRIPLA 170 30 22 267
TRUVADA 161 0 23 213
CITALOPRAM HBR 151 91 24 19
NEXIUM 150 53 25 53
ATENOLOL 150 121 25 11
FLUOXETINE HCL 145 64 27 48
DIGOXIN 142 126 28 39
TRAZODONE HCL 133 53 29 45
PANTOPRAZOLE SODIUM 124 76 30 34
JANUVIA 123 78 31 81
CARVEDILOL 122 122 32 30
LOSARTAN POTASSIUM 117 104 33 16
SPIRONOLACTONE 115 85 34 44
ISENTRESS 114 0 35 244
DONEPEZIL HCL 112 100 36 24
TRAMADOL HCL 111 69 37 21
NAPROXEN 110 68 38 113
RAMIPRIL 107 90 39 144
DOXEPIN HCL 102 67 40 305
CYCLOBENZAPRINE HCL 100 22 R 41 86
MIRTAZAPINE 99 57 42 35
POTASSIUM CHLORIDE 96 81 43 15
NORVIR 95 0 44 216
SERTRALINE HCL 95 57 44 23
PROAIR HFA 91 19 46 56
ESTRADIOL 90 36 R 47 207
MORPHINE SULFATE ER 87 14 S2 48 80
CRESTOR 86 68 49 28
LYRICA 85 35 50 114
AMLODIPINE BESYLATE-BENAZEPRIL 84 61 51 118
ADVAIR DISKUS 80 48 52 31
BENAZEPRIL HCL 78 74 53 66
PREDNISONE 75 44 54 32
LOSARTAN-HYDROCHLOROTHIAZIDE 72 69 55 54
DIOVAN 72 47 55 38
AZITHROMYCIN 70 47 57 70
DICLOFENAC SODIUM 70 43 57 106
CLOPIDOGREL 69 66 59 36
GLYBURIDE-METFORMIN HCL 69 32 R 59 132
ZOLPIDEM TARTRATE 68 53 61 25
SPIRIVA 68 22 61 65
TRIAMCINOLONE ACETONIDE 67 53 63 105
BUPROPION XL 67 28 63 329
ENALAPRIL MALEATE 67 54 63 43
ABILIFY 67 13 63 166
FENTANYL 67 12 S2 63 57
REYATAZ 64 0 68 255
ACTOS 62 45 69 128
ALENDRONATE SODIUM 61 38 70 20
DIOVAN HCT 59 46 71 108
OXYCODONE-ACETAMINOPHEN 59 16 S2 71 62
METFORMIN HCL ER 55 53 73 49
KETOCONAZOLE 54 31 74 248
CYMBALTA 53 24 75 75
PLAVIX 52 43 76 55
NAMENDA 51 51 77 37
GEMFIBROZIL 51 20 77 72
NADOLOL 51 39 77 209
LANTUS SOLOSTAR 51 43 77 61
INTELENCE 51 0 77 369
FLUTICASONE PROPIONATE 51 36 77 40
CELEBREX 50 36 83 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.